Last 12 months
Inside the activity.
0 purchase rows · 65 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 9 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 12 |
| Jul 2026 | 0 | 6 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 21 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2021 Filed Apr 2, 2021 20:17 UTC |
BLASING KARENDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 500 | $0.00 Strike: $5.82 | $0.00 |
DisclosureSEC source: 0001713683-21-000060 · wf-form4_161739461049973.xml · derivative · entry 4 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,334 Underlying: Common Stock · 500 shares Expires 2027-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on February 1, 2017. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 20:17 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 500 | $180.00 | $90,000.00 |
DisclosureSEC source: 0001713683-21-000060 · wf-form4_161739461049973.xml · nonDerivative · entry 2 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,763 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 20:17 UTC |
BLASING KARENDirector
|
Exercise / conversionCommon Stock | 500 | $5.82 | $2,910.00 |
DisclosureSEC source: 0001713683-21-000060 · wf-form4_161739461049973.xml · nonDerivative · entry 1 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,263 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 20:18 UTC |
Sinha AmitDirector · President of R&D and CTO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $5.93 | $0.00 |
DisclosureSEC source: 0001713683-21-000061 · wf-form4_161739466611966.xml · derivative · entry 13 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,333 Underlying: Common Stock · 7,000 shares Expires 2027-04-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_date: One-fourth of the shares subject to the option vest on November 1, 2018 and 1/48 of the shares vest monthly thereafter. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 20:18 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 200 | $179.58 | $35,915.00 |
DisclosureSEC source: 0001713683-21-000061 · wf-form4_161739466611966.xml · nonDerivative · entry 6 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,533 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F6 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $179.32 to $179.83, inclusive. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 20:18 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 1,600 | $178.29 | $285,266.08 |
DisclosureSEC source: 0001713683-21-000061 · wf-form4_161739466611966.xml · nonDerivative · entry 5 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,733 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F5 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $177.85 to $178.82, inclusive. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 20:18 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 2,400 | $177.31 | $425,538.96 |
DisclosureSEC source: 0001713683-21-000061 · wf-form4_161739466611966.xml · nonDerivative · entry 4 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,333 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F4 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $176.80 to $177.77, inclusive. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 20:18 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 2,000 | $176.34 | $352,688.00 |
DisclosureSEC source: 0001713683-21-000061 · wf-form4_161739466611966.xml · nonDerivative · entry 3 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,733 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F3 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $175.80 to $176.79, inclusive. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 20:18 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 800 | $175.43 | $140,340.48 |
DisclosureSEC source: 0001713683-21-000061 · wf-form4_161739466611966.xml · nonDerivative · entry 2 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,733 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $174.71 to $175.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (6) to this Form 4. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 20:18 UTC |
Sinha AmitDirector · President of R&D and CTO
|
Exercise / conversionCommon Stock | 7,000 | $5.93 | $41,475.00 |
DisclosureSEC source: 0001713683-21-000061 · wf-form4_161739466611966.xml · nonDerivative · entry 1 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,533 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 29, 2021 Filed Mar 30, 2021 22:00 UTC |
BLASING KARENDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,500 | $0.00 Strike: $5.82 | $0.00 |
DisclosureSEC source: 0001713683-21-000057 · wf-form4_161714158997929.xml · derivative · entry 8 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,834 Underlying: Common Stock · 1,500 shares Expires 2027-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The shares subject to the options are fully vested and immediately exercisable. Read SEC document |
| March 29, 2021 Filed Mar 30, 2021 22:00 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 200 | $169.70 | $33,940.00 |
DisclosureSEC source: 0001713683-21-000057 · wf-form4_161714158997929.xml · nonDerivative · entry 6 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,763 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F4 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $169.31 to $170.09, inclusive. Read SEC document |
| March 29, 2021 Filed Mar 30, 2021 22:00 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 100 | $167.35 | $16,735.00 |
DisclosureSEC source: 0001713683-21-000057 · wf-form4_161714158997929.xml · nonDerivative · entry 5 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,963 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. Read SEC document |
| March 29, 2021 Filed Mar 30, 2021 22:00 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 500 | $166.22 | $83,112.00 |
DisclosureSEC source: 0001713683-21-000057 · wf-form4_161714158997929.xml · nonDerivative · entry 4 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,063 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F3 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $165.94 to $166.90, inclusive. Read SEC document |
| March 29, 2021 Filed Mar 30, 2021 22:00 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 600 | $165.23 | $99,139.98 |
DisclosureSEC source: 0001713683-21-000057 · wf-form4_161714158997929.xml · nonDerivative · entry 3 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,563 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $164.89 to $165.76, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (4) to this Form 4. Read SEC document |
| March 29, 2021 Filed Mar 30, 2021 22:00 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 100 | $163.86 | $16,386.00 |
DisclosureSEC source: 0001713683-21-000057 · wf-form4_161714158997929.xml · nonDerivative · entry 2 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,163 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. Read SEC document |
| March 29, 2021 Filed Mar 30, 2021 22:00 UTC |
BLASING KARENDirector
|
Exercise / conversionCommon Stock | 1,500 | $5.82 | $8,730.00 |
DisclosureSEC source: 0001713683-21-000057 · wf-form4_161714158997929.xml · nonDerivative · entry 1 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,263 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 18, 2021 Filed Mar 19, 2021 20:09 UTC |
Sinha AmitDirector · President of R&D and CTO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $5.93 | $0.00 |
DisclosureSEC source: 0001713683-21-000055 · wf-form4_161618457603507.xml · derivative · entry 14 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,333 Underlying: Common Stock · 7,000 shares Expires 2027-04-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F14 · derivative.exercise_date: One-fourth of the shares subject to the option vest on November 1, 2018 and 1/48 of the shares vest monthly thereafter. Read SEC document |
| March 18, 2021 Filed Mar 19, 2021 20:09 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 300 | $184.17 | $55,251.99 |
DisclosureSEC source: 0001713683-21-000055 · wf-form4_161618457603507.xml · nonDerivative · entry 7 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,533 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F7 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $183.97 to $184.56, inclusive. Read SEC document |
| March 18, 2021 Filed Mar 19, 2021 20:09 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 900 | $183.12 | $164,806.02 |
DisclosureSEC source: 0001713683-21-000055 · wf-form4_161618457603507.xml · nonDerivative · entry 6 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,833 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F6 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $182.62 to $183.65, inclusive. Read SEC document |
| March 18, 2021 Filed Mar 19, 2021 20:09 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 1,831 | $181.84 | $332,954.72 |
DisclosureSEC source: 0001713683-21-000055 · wf-form4_161618457603507.xml · nonDerivative · entry 5 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,733 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F5 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $181.55 to $182.42, inclusive. Read SEC document |
| March 18, 2021 Filed Mar 19, 2021 20:09 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 1,300 | $180.78 | $235,018.94 |
DisclosureSEC source: 0001713683-21-000055 · wf-form4_161618457603507.xml · nonDerivative · entry 4 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,564 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F4 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $180.38 to $181.26, inclusive. Read SEC document |
| March 18, 2021 Filed Mar 19, 2021 20:09 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 700 | $179.57 | $125,695.99 |
DisclosureSEC source: 0001713683-21-000055 · wf-form4_161618457603507.xml · nonDerivative · entry 3 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,864 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F3 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $179.10 to $180.04, inclusive. Read SEC document |
| March 18, 2021 Filed Mar 19, 2021 20:09 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 1,969 | $178.59 | $351,643.32 |
DisclosureSEC source: 0001713683-21-000055 · wf-form4_161618457603507.xml · nonDerivative · entry 2 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,564 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.07 to $178.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (7) to this Form 4. Read SEC document |
| March 18, 2021 Filed Mar 19, 2021 20:09 UTC |
Sinha AmitDirector · President of R&D and CTO
|
Exercise / conversionCommon Stock | 7,000 | $5.93 | $41,475.00 |
DisclosureSEC source: 0001713683-21-000055 · wf-form4_161618457603507.xml · nonDerivative · entry 1 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,533 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 17, 2021 Filed Mar 18, 2021 21:46 UTC |
Schlossman RobertChief Legal Officer
|
SaleCommon Stock | 313 | $187.88 | $58,807.72 |
DisclosureSEC source: 0001713683-21-000053 · wf-form4_161610397629990.xml · nonDerivative · entry 7 Schlossman Robert · CIK 0001435941 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,154 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on July 7, 2020. F7 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $187.78 to $188.19, inclusive. Read SEC document |
| March 17, 2021 Filed Mar 18, 2021 21:46 UTC |
Schlossman RobertChief Legal Officer
|
SaleCommon Stock | 100 | $186.65 | $18,665.00 |
DisclosureSEC source: 0001713683-21-000053 · wf-form4_161610397629990.xml · nonDerivative · entry 6 Schlossman Robert · CIK 0001435941 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,467 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on July 7, 2020. Read SEC document |
| March 17, 2021 Filed Mar 18, 2021 21:46 UTC |
Schlossman RobertChief Legal Officer
|
SaleCommon Stock | 601 | $185.65 | $111,576.37 |
DisclosureSEC source: 0001713683-21-000053 · wf-form4_161610397629990.xml · nonDerivative · entry 5 Schlossman Robert · CIK 0001435941 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,567 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on July 7, 2020. F6 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $185.34 to $186.18, inclusive. Read SEC document |
| March 17, 2021 Filed Mar 18, 2021 21:46 UTC |
Schlossman RobertChief Legal Officer
|
SaleCommon Stock | 200 | $184.27 | $36,853.00 |
DisclosureSEC source: 0001713683-21-000053 · wf-form4_161610397629990.xml · nonDerivative · entry 4 Schlossman Robert · CIK 0001435941 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,168 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on July 7, 2020. F5 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $184.15 to $184.38, inclusive. Read SEC document |
| March 17, 2021 Filed Mar 18, 2021 21:46 UTC |
Schlossman RobertChief Legal Officer
|
SaleCommon Stock | 400 | $183.34 | $73,334.00 |
DisclosureSEC source: 0001713683-21-000053 · wf-form4_161610397629990.xml · nonDerivative · entry 3 Schlossman Robert · CIK 0001435941 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,368 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on July 7, 2020. F4 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $183.01 to $183.79, inclusive. Read SEC document |
| March 17, 2021 Filed Mar 18, 2021 21:46 UTC |
Schlossman RobertChief Legal Officer
|
SaleCommon Stock | 300 | $182.29 | $54,686.01 |
DisclosureSEC source: 0001713683-21-000053 · wf-form4_161610397629990.xml · nonDerivative · entry 2 Schlossman Robert · CIK 0001435941 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,768 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on July 7, 2020. F3 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $181.85 to $182.51, inclusive. Read SEC document |
| March 17, 2021 Filed Mar 18, 2021 21:46 UTC |
Schlossman RobertChief Legal Officer
|
SaleCommon Stock | 600 | $180.45 | $108,267.00 |
DisclosureSEC source: 0001713683-21-000053 · wf-form4_161610397629990.xml · nonDerivative · entry 1 Schlossman Robert · CIK 0001435941 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,068 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on July 7, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $179.95 to $180.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4) to this Form 4. Read SEC document |
| March 16, 2021 Filed Mar 16, 2021 21:09 UTC |
Rajic DaliPres Go-To-Mkt/ Chief Rev Ofcr
|
SaleCommon Stock | 14,090 | $183.31 | $2,582,837.90 |
DisclosureSEC source: 0001713683-21-000048 · wf-form4_161594337622935.xml · nonDerivative · entry 1 Rajic Dali · CIK 0001695005 · Pres Go-To-Mkt/ Chief Rev Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,497 F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units as mandated by the Issuer's election under its equity incentive plans and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| March 16, 2021 Filed Mar 17, 2021 01:10 UTC |
Schlossman RobertChief Legal Officer
|
SaleCommon Stock | 3,104 | $183.31 | $568,994.24 |
DisclosureSEC source: 0001713683-21-000049 · wf-form4_161594339902084.xml · nonDerivative · entry 1 Schlossman Robert · CIK 0001435941 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,668 F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units as mandated by the Issuer's election under its equity incentive plans and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| March 16, 2021 Filed Mar 16, 2021 21:09 UTC |
CANESSA REMOChief Financial Officer
|
SaleCommon Stock | 4,699 | $183.31 | $861,373.69 |
DisclosureSEC source: 0001713683-21-000047 · wf-form4_161594335462120.xml · nonDerivative · entry 1 CANESSA REMO · CIK 0001250311 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 302,889 F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units as mandated by the Issuer's election under its equity incentive plans and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| March 16, 2021 Filed Mar 17, 2021 01:19 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 8,113 | $183.31 | $1,487,194.03 |
DisclosureSEC source: 0001713683-21-000050 · wf-form4_161594393461931.xml · nonDerivative · entry 1 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,533 F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units as mandated by the Issuer's election under its equity incentive plans and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 01:19 UTC |
BLASING KARENDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $5.82 | $0.00 |
DisclosureSEC source: 0001713683-21-000051 · wf-form4_161594395967463.xml · derivative · entry 7 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,334 Underlying: Common Stock · 2,000 shares Expires 2027-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The shares subject to the options are fully vested and immediately exercisable. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 01:19 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 500 | $184.98 | $92,490.00 |
DisclosureSEC source: 0001713683-21-000051 · wf-form4_161594395967463.xml · nonDerivative · entry 5 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,763 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 01:19 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 790 | $183.85 | $145,239.53 |
DisclosureSEC source: 0001713683-21-000051 · wf-form4_161594395967463.xml · nonDerivative · entry 4 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,263 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F4 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $183.33 to $184.22, inclusive. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 01:19 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 500 | $182.84 | $91,419.00 |
DisclosureSEC source: 0001713683-21-000051 · wf-form4_161594395967463.xml · nonDerivative · entry 3 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,053 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F3 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $182.19 to $183.17, inclusive. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 01:19 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 210 | $181.36 | $38,086.10 |
DisclosureSEC source: 0001713683-21-000051 · wf-form4_161594395967463.xml · nonDerivative · entry 2 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,553 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $181.07 to $181.91, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4) to this Form 4. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 01:19 UTC |
BLASING KARENDirector
|
Exercise / conversionCommon Stock | 2,000 | $5.82 | $11,640.00 |
DisclosureSEC source: 0001713683-21-000051 · wf-form4_161594395967463.xml · nonDerivative · entry 1 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 20:22 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 2,000 | $187.00 | $374,000.00 |
DisclosureSEC source: 0001713683-21-000041 · wf-form4_161583972441104.xml · nonDerivative · entry 2 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 53,000 F2 · ownership.nature: The shares are held of record by the South Dakota Trust Co. LLC TTEE Sinha Family Incentive Trust Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 20:22 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 2,000 | $187.00 | $374,000.00 |
DisclosureSEC source: 0001713683-21-000041 · wf-form4_161583972441104.xml · nonDerivative · entry 1 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 53,000 F1 · ownership.nature: The shares are held of record by the South Dakota Trust Co. LLC TTEE Sinha Education Excellence Trust. Read SEC document |
| March 04, 2021 Filed Mar 8, 2021 21:58 UTC |
Sinha AmitDirector · President of R&D and CTO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $5.93 | $0.00 |
DisclosureSEC source: 0001713683-21-000039 · wf-form4_161524069989755.xml · derivative · entry 19 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,333 Underlying: Common Stock · 7,000 shares Expires 2027-04-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F17 · derivative.exercise_date: One-fourth of the shares subject to the option vest on November 1, 2018 and 1/48 of the shares vest monthly thereafter. Read SEC document |
| March 04, 2021 Filed Mar 8, 2021 21:58 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 100 | $189.50 | $18,950.00 |
DisclosureSEC source: 0001713683-21-000039 · wf-form4_161524069989755.xml · nonDerivative · entry 12 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,646 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. Read SEC document |
| March 04, 2021 Filed Mar 8, 2021 21:58 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 700 | $188.22 | $131,754.00 |
DisclosureSEC source: 0001713683-21-000039 · wf-form4_161524069989755.xml · nonDerivative · entry 11 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,746 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F10 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $187.82 to $188.76, inclusive. Read SEC document |
| March 04, 2021 Filed Mar 8, 2021 21:58 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 716 | $187.12 | $133,979.42 |
DisclosureSEC source: 0001713683-21-000039 · wf-form4_161524069989755.xml · nonDerivative · entry 10 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,446 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F9 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $186.72 to $187.54, inclusive. Read SEC document |
| March 04, 2021 Filed Mar 8, 2021 21:58 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 900 | $185.97 | $167,373.99 |
DisclosureSEC source: 0001713683-21-000039 · wf-form4_161524069989755.xml · nonDerivative · entry 9 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,162 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F8 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $185.49 to $186.46, inclusive. Read SEC document |
| March 04, 2021 Filed Mar 8, 2021 21:58 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 430 | $184.20 | $79,207.12 |
DisclosureSEC source: 0001713683-21-000039 · wf-form4_161524069989755.xml · nonDerivative · entry 8 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,062 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F7 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $183.61 to $184.59, inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.